Publication:
Comparison of susceptibility testing methods for determining the activity of colistin against Gram-negative bacilli of clinical origin.

dc.contributor.authorHaeili, Mehri
dc.contributor.authorKafshdouz, Mahsa
dc.contributor.authorPishnian, Zeinab
dc.contributor.authorFeizabadi, Mohammad Mehdi
dc.contributor.authorMartinez-Martinez, Luis
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderMinisterio de Economía y Competitividad
dc.contributor.funderEuropean Development Regional Fund “A Way to Achieve Europe” ERDF
dc.date.accessioned2023-01-25T10:24:19Z
dc.date.available2023-01-25T10:24:19Z
dc.date.issued2018-12-05
dc.description.abstractDespite being in clinical use for decades, colistin susceptibility testing remains challenging because of its inherent cationic properties. We aimed to compare the performance characteristics of different methods for testing susceptibility to colistin in a series of clinical isolates of Gram-negative bacilli. One hundred and nine clinical isolates of Klebsiella pneumoniae (n=34), Escherichia coli (n=20), Acinetobacter baumannii (n=17) and Pseudomonas aeruginosa (n=38) were studied for colistin susceptibility using broth microdilution (BMID), broth macrodilution (BMAD), agar dilution (AD) as well as disc-diffusion (DD) utilizing two different commercial disc sources. By using BMID as reference method, 88 and 21 isolates were found to be colistin susceptible and resistant, respectively. Overall, acceptable essential agreement (EA) and categorical agreement (CA) were observed between BMAD and reference method (100 %). Whereas the AD method revealed the lowest rate of EA (61.7, 11.7, 5.0 and 5.2 % for K. pneumoniae, A. baumannii, E. coli and P. aeruginosa, respectively), it showed acceptable or near acceptable CA for K. pneumoniae (100 %), E. coli (100 %) and A. baumannii (88.2 %) isolates but not for P. aeruginosa (13.1 %). DD failed to detect resistance in colistin-resistant (colR) P. aeruginosa (n=5, very major errors of 100 %) but successfully identified all high-level colistin-resistant A. baumannii and K. pneumoniae isolates. We found BMAD to be very reliable for colistin MIC determination. Methods AD and DD should not be used for colistin susceptibility testing in P. aeruginosa isolates as these are associated with false-resistant and -susceptible results, respectively.
dc.identifier.citationHaeili M, Kafshdouz M, Pishnian Z, Feizabadi MM, Martinez-Martinez L. Comparison of susceptibility testing methods for determining the activity of colistin against Gram-negative bacilli of clinical origin. J Med Microbiol. 2019 Jan;68(1):60-66.
dc.identifier.doi10.1099/jmm.0.000879
dc.identifier.essn1473-5644
dc.identifier.pmid30422106
dc.identifier.unpaywallURLhttps://doi.org/10.1099/jmm.0.000879
dc.identifier.urihttp://hdl.handle.net/10668/13176
dc.issue.number1
dc.journal.titleJournal of medical microbiology
dc.journal.titleabbreviationJ Med Microbiol
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.page.number60-66
dc.publisherThe Microbiology Society
dc.pubmedtypeComparative Study
dc.pubmedtypeJournal Article
dc.relation.projectIDPI17/022241
dc.relation.projectIDRD16/0016/0008
dc.relation.publisherversionhttp://jmm.microbiologyresearch.org/pubmed/content/journal/jmm/10.1099/jmm.0.000879
dc.rights.accessRightsopen access
dc.subjectAgar dilution
dc.subjectBroth macrodilution
dc.subjectBroth microdilution
dc.subjectColistin
dc.subjectSusceptibility testing
dc.subject.decsAntibacterianos
dc.subject.decsBacterias gramnegativas
dc.subject.decsColistina
dc.subject.decsFarmacorresistencia bacteriana
dc.subject.decsInfecciones por bacterias gramnegativas
dc.subject.decsPruebas de sensibilidad microbiana
dc.subject.meshAnti-bacterial agents
dc.subject.meshColistin
dc.subject.meshDrug resistance, bacterial
dc.subject.meshGram-negative bacteria
dc.subject.meshGram-negative bacterial infections
dc.subject.meshHumans
dc.subject.meshMicrobial sensitivity tests
dc.titleComparison of susceptibility testing methods for determining the activity of colistin against Gram-negative bacilli of clinical origin.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number68
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format